EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access

Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration

Nicolas Grillot, Gilles Lebuffe, Olivier Huet, Sigismond Lasocki, Xavier Pichon, Mathieu Oudot, Nathalie Bruneau, Jean-Stéphane David, Pierre Bouzat, Alexandra Jobert, Martine Tching-Sin, Fanny Feuillet und 4 weitere

JAMA · 03.01.2023 · 329 (1) · 28

DOI: 10.1001/jama.2022.23550 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA, erschienen am 03.01.2023. Verfasst von Nicolas Grillot und 15 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, CHU Nantes, Service d'Anesthésie Réanimation Chirurgicale, INSERM CIC 0004 Immunologie et Infectiologie, Nantes, France. Hauptthemen laut MEDLINE: Intubation, Intratracheal, Neuromuscular Blocking Agents, Rapid Sequence Induction and Intubation, Remifentanil. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance It is uncertain whether a rapid-onset opioid is noninferior to a rapid-onset neuromuscular blocker during rapid sequence intubation when used in conjunction with a hypnotic agent.

Objective

To determine whether remifentanil is noninferior to rapid-onset neuromuscular blockers for rapid sequence intubation. Design, Setting, and Participants Multicenter, randomized, open-label, noninferiority trial among 1150 adults at risk of aspiration (fasting for <6 hours, bowel occlusion, recent trauma, or severe gastroesophageal reflux) who underwent tracheal intubation in the operating room at 15 hospitals in France from October 2019 to April 2021. Follow-up was completed on May 15, 2021.

Interventions

Patients were randomized to receive neuromuscular blockers (1 mg/kg of succinylcholine or rocuronium; n = 575) or remifentanil (3 to 4 μg/kg; n = 575) immediately after injection of a hypnotic. Main Outcomes and Measures The primary outcome was assessed in all randomized patients (as-randomized population) and in all eligible patients who received assigned treatment (per-protocol population). The primary outcome was successful tracheal intubation on the first attempt without major complications, defined as lung aspiration of digestive content, oxygen desaturation, major hemodynamic instability, sustained arrhythmia, cardiac arrest, and severe anaphylactic reaction. The prespecified noninferiority margin was 7.0%.

Results

Among 1150 randomized patients (mean age, 50.7 [SD, 17.4] years; 573 [50%] women), 1130 (98.3%) completed the trial. In the as-randomized population, tracheal intubation on the first attempt without major complications occurred in 374 of 575 patients (66.1%) in the remifentanil group and 408 of 575 (71.6%) in the neuromuscular blocker group (between-group difference adjusted for randomization strata and center, –6.1%; 95% CI, –11.6% to –0.5%; P = .37 for noninferiority), demonstrating inferiority. In the per-protocol population, 374 of 565 patients (66.2%) in the remifentanil group and 403 of 565 (71.3%) in the neuromuscular blocker group had successful intubation without major complications (adjusted difference, –5.7%; 2-sided 95% CI, –11.3% to –0.1%; P = .32 for noninferiority). An adverse event of hemodynamic instability was recorded in 19 of 575 patients (3.3%) with remifentanil and 3 of 575 (0.5%) with neuromuscular blockers (adjusted difference, 2.8%; 95% CI, 1.2%-4.4%). Conclusions and Relevance Among adults at risk of aspiration during rapid sequence intubation in the operating room, remifentanil, compared with neuromuscular blockers, did not meet the criterion for noninferiority with regard to successful intubation on first attempt without major complications. Although remifentanil was statistically inferior to neuromuscular blockers, the wide confidence interval around the effect estimate remains compatible with noninferiority and limits conclusions about the clinical relevance of the difference. Trial Registration ClinicalTrials.gov Identifier: NCT03960801

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intubation, IntratrachealNeuromuscular Blocking AgentsRapid Sequence Induction and IntubationRemifentanilRespiratory AspirationAnalgesics, OpioidAdultFemaleHumansMaleMiddle AgedHypnotics and SedativesAged

Substanzen

Hypnotics and SedativesNeuromuscular Blocking AgentsRemifentanilAnalgesics, Opioid

Autor:innen und Institutionen

  • Nantes Université, CHU Nantes, Service d'Anesthésie Réanimation Chirurgicale, INSERM CIC 0004 Immunologie et Infectiologie, Nantes, France.
  • Université Lille, CHU Lille, ULR 7354-GRITA Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Pôle Anesthésie Réanimation, Lille, France.
  • Département d'Anesthésie Réanimation et Médecine Péri-opératoire, CHRU Brest, Université de Bretagne occidentale, Brest, France.
  • Department of Anesthesiology and Critical Care Medicine, University Hospital of Angers, Angers, France.
  • Department of Anesthesiology and Critical Care Medicine, University Hospital of Toulouse, University Toulouse III-Paul-Sabatier, Toulouse, France.
  • Department of Anesthesiology, Centre Hospitalier Departemental, La Roche sur Yon, France.

Zitieren

APA

Grillot, N., Lebuffe, G., Huet, O., Lasocki, S., Pichon, X., Oudot, M., Bruneau, N., David, J. S., Bouzat, P., Jobert, A., Tching-Sin, M., Feuillet, F., Cinotti, R., Asehnoune, K., Roquilly, A., & Atlanrea Study GroupSociété Française d’Anesthésie Réanimation (SFAR) Research Network (2023). Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration. JAMA, 329(1), 28. https://doi.org/10.1001/jama.2022.23550

Vancouver

Grillot N, Lebuffe G, Huet O, Lasocki S, Pichon X, Oudot M, et al. Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration. JAMA. 2023;329(1):28. doi:10.1001/jama.2022.23550

BibTeX
@article{Grillot2023,
  author = {Grillot, Nicolas and Lebuffe, Gilles and Huet, Olivier and Lasocki, Sigismond and Pichon, Xavier and Oudot, Mathieu and Bruneau, Nathalie and David, Jean-Stéphane and Bouzat, Pierre and Jobert, Alexandra and Tching-Sin, Martine and Feuillet, Fanny and Cinotti, Raphael and Asehnoune, Karim and Roquilly, Antoine and Atlanrea Study GroupSociété Française d’Anesthésie Réanimation (SFAR) Research Network, Atlanrea Study GroupSociété Française d’Anesthésie Réanimation (SFAR) Research Network},
  title = {Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration},
  journal = {JAMA},
  year = {2023},
  volume = {329},
  number = {1},
  pages = {28},
  doi = {10.1001/jama.2022.23550}
}
Kostenlos starten →